Stanford University Hospital
Stanford, California, 94305, United States
NCT Number: NCT06689215
Comparison of a non-invasive method of measuring central venous pressure to the conventional modality of invasive central venous pressure.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Stanford, California, 94305, United States
The conventional method used to measure central venous pressure has limitations since it is an invasive procedure that requires a central venous catheter. To overcome this challenge, a new technology to assess CVP non-invasively using an oscillometric method is being developed. It is called enclosed zone central venous pressure (ezCVP). A comparison study of ezCVP and CVP is needed to determine accuracy and reproducibility.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-invasive method to measure central venous pressure indicator
Other names: ezCVP, CVPni
Time frame: 1-7 days
Evaluate sensitivity and specificity of ezCVP indication based on the case where CVP is in a 'low range' (0 < CVP < 10 mmHg) or 'high range' (>= 10 mmHg)
Time frame: 1-7 days
Correlate the directionality of ezCVP change to invasive CVP change over time (i.e., increasing, decreasing or remaining stable).
Time frame: 1-7 days
Quantify the agreement between ezCVP (non-invasive) and CVP (invasive)
Nihon Kohden
Industry
Comparison Study of ezCVP and CVP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07656428
Cardiovascular Diseases, Digestive System Diseases
Taipei, Taiwan
View Trial DetailsNCT00005133
Brain Diseases, Cardiovascular Diseases
Sacramento, California, United States
View Trial DetailsNCT05677100
ADHF, Cardio-Renal Syndrome
Phoenix, Arizona, United States
View Trial DetailsNCT00181259
Cardiovascular Diseases, Heart Diseases
Baltimore, Maryland, United States
View Trial Details